Medindia

X

Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials

Wednesday, July 21, 2010 Research News J E 4
Advertisement


NEW YORK, July 20 Target Health Inc. and LifeOnKey, Inc. today announced they have joined forces to offer an innovative, web-based information platform that will allow the bio-pharmaceutical and medical device industries to optimize clinical trials, help researchers capture, analyze and assess trial data more efficiently, and bring innovative new medicines and devices to patients.

Through its partnership with LifeOnKey, Target Health can provide health care companies with an electronic clinical trial record that can manage and monitor the care of clinical trial patients from Phase I through Phase IV post-marketing surveillance.

By combining Target Health's clinical trial software with LifeOnKey's electronic health records (EHRs), the partnership will give clinicians online access to the most recent medical information for their clinical trial patients, allowing them to efficiently track critical information - from side effects to health improvements, while maintaining the integrity of the clinical trial data. Meanwhile, patients will gain the ability to follow the progress of the clinical trial through their own patient health record.

"We are very enthusiastic about building a comprehensive solution that integrates clinical trial software and EHRs - the first offering of its kind for this industry," said Target Health President Dr. Jules Mitchel. "This partnership leverages the deep expertise with clinical trials and information systems within both companies to enhance the efficiency of the drug, biologic and device development process."

"This partnership clearly highlights the ultimate promise of health information technology," said Dr. Linda Harnevo, CEO of LifeOnKey. "Through the smart application of information technology, we can help clinicians improve the clinical trial process from end-to-end - from better patient recruitment to more effective patient monitoring once the drug is on the market."

According to Dr. Mitchel and Dr. Harnevo, the Target Health-LifeOnKey partnership will also ensure better compliance with clinical trial requirements and help medical researchers track specific patient groups, follow product use and evaluate patient outcomes over the long term.

About Target Health Inc.

Target Health, established in 1993, is a full-service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, comprising, but not limited to, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, EDC utilizing Target e*CRF®, and Medical Writing. Target Health has developed a full suite of eClinical Trial software including Target e*CRF® (EDC plus randomization and batch edit checks); Target e*CTMS(TM); Target Document®; (paperless TMF and beyond); Target Encoder® (for MedDRA and WHO Drug); and Target Newsletter®. Target Health's Pharmaceutical Advisory Dream Team assists companies in strategic planning from Discovery to Market Launch.

www.targethealth.com

About LifeOnKey, Inc.

LifeOnKey is a leader in personalized health technology solutions. LifeOnKey transforms the way health information is collected, managed and analyzed by major health care stakeholders and used by individuals to improve wellness and self-care. LifeOnKey's three primary applications - an electronic health record (EHR), a personal health record (PHR) and a Research Center - are seamlessly integrated, delivering relevant data that can be targeted to the needs of each unique user. The company currently has 1.5 million patient users globally. LifeOnKey's headquarters are located in New York and its R&D in Herzliya, Israel.

www.lifeonkey.com

SOURCE Target Health Inc.; LifeOnKey, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mindray to Report Second Quarter 2010 Financial Re...
S
Aware Biometrics Software Provided for Large Feder...